[go: up one dir, main page]

DK1524272T3 - Væksthormonsekretionsfremmere - Google Patents

Væksthormonsekretionsfremmere

Info

Publication number
DK1524272T3
DK1524272T3 DK05075086T DK05075086T DK1524272T3 DK 1524272 T3 DK1524272 T3 DK 1524272T3 DK 05075086 T DK05075086 T DK 05075086T DK 05075086 T DK05075086 T DK 05075086T DK 1524272 T3 DK1524272 T3 DK 1524272T3
Authority
DK
Denmark
Prior art keywords
growth hormone
hormone
growth
Prior art date
Application number
DK05075086T
Other languages
Danish (da)
English (en)
Inventor
Jean Martinez
Vincent Guerlavais
Jean-Alain Fehrentz
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Application granted granted Critical
Publication of DK1524272T3 publication Critical patent/DK1524272T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • AIDS & HIV (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
DK05075086T 2000-06-13 2001-06-13 Væksthormonsekretionsfremmere DK1524272T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21132600P 2000-06-13 2000-06-13
US23492800P 2000-09-26 2000-09-26
PCT/EP2001/006717 WO2001096300A1 (en) 2000-06-13 2001-06-13 Growth hormone secretagogues

Publications (1)

Publication Number Publication Date
DK1524272T3 true DK1524272T3 (da) 2007-09-03

Family

ID=26906052

Family Applications (3)

Application Number Title Priority Date Filing Date
DK03075950T DK1344773T3 (da) 2000-06-13 2001-06-13 Væksthormonsekretionsfremmere
DK05075086T DK1524272T3 (da) 2000-06-13 2001-06-13 Væksthormonsekretionsfremmere
DK01943504T DK1289951T3 (da) 2000-06-13 2001-06-13 Væksthormon sekretionsfremmere

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK03075950T DK1344773T3 (da) 2000-06-13 2001-06-13 Væksthormonsekretionsfremmere

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK01943504T DK1289951T3 (da) 2000-06-13 2001-06-13 Væksthormon sekretionsfremmere

Country Status (29)

Country Link
US (2) US6861409B2 (pt)
EP (1) EP1289951B1 (pt)
JP (2) JP3522265B2 (pt)
KR (1) KR100825109B1 (pt)
CN (1) CN1232507C (pt)
AR (1) AR029941A1 (pt)
AT (3) ATE362472T1 (pt)
AU (2) AU6606601A (pt)
BG (3) BG66130B1 (pt)
BR (1) BRPI0111591B8 (pt)
CA (1) CA2407659C (pt)
CY (2) CY1107710T1 (pt)
CZ (2) CZ305279B6 (pt)
DE (3) DE60128494T2 (pt)
DK (3) DK1344773T3 (pt)
ES (3) ES2292900T3 (pt)
FR (1) FR19C1044I2 (pt)
HU (1) HU229233B1 (pt)
IL (2) IL153067A0 (pt)
MX (1) MXPA02011899A (pt)
NL (1) NL300999I2 (pt)
NO (1) NO323873B1 (pt)
NZ (1) NZ522280A (pt)
PL (1) PL216676B1 (pt)
PT (2) PT1344773E (pt)
RU (1) RU2270198C2 (pt)
SK (1) SK287169B6 (pt)
TW (2) TW200831076A (pt)
WO (1) WO2001096300A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2407659C (en) * 2000-06-13 2010-11-09 Zentaris Ag Growth hormone secretagogues
CU23157A1 (es) * 2001-01-03 2006-07-18 Ct Ingenieria Genetica Biotech COMPOSICION FARMACéUTICA PARA EL TRATAMIENTO DEL DANO TISULAR DEBIDO A FALTA DE IRRIGACION SANGUINEA ARTERIAL
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
US7034050B2 (en) * 2004-04-28 2006-04-25 Romano Deghenghi Pseudopeptides growth hormone secretagogues
US8138218B2 (en) * 2005-07-22 2012-03-20 Ipsen Pharma S.A.S. Growth hormone secretagogues
EP1757290A1 (en) 2005-08-16 2007-02-28 Zentaris GmbH Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
GB0603295D0 (en) * 2006-02-18 2006-03-29 Ardana Bioscience Ltd Methods and kits
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
US7763707B2 (en) * 2006-03-13 2010-07-27 Liat Mintz Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation
ES2602789T3 (es) 2007-02-09 2017-02-22 Ocera Therapeutics, Inc. Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina
EP2103602A1 (en) 2008-03-17 2009-09-23 AEterna Zentaris GmbH Novel 1,2,4-triazole derivatives and process of manufacturing thereof
US8431642B2 (en) * 2008-06-09 2013-04-30 Exxonmobil Chemical Patents Inc. Polyolefin adhesive compositions and articles made therefrom
EP2431035A1 (en) 2010-09-16 2012-03-21 Æterna Zentaris GmbH Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
US9198889B2 (en) 2012-09-19 2015-12-01 Quality IP Holdings, LLC Methods for treating post-traumatic stress disorder
US8747921B2 (en) 2012-09-19 2014-06-10 Quality Ip Holdings, Inc. Methods for improving health in humans
US10300101B2 (en) 2012-09-19 2019-05-28 Quality IP Holdings, LLC Methods and compositions for enhancing or maintaining fertility
US8747922B2 (en) 2012-09-19 2014-06-10 Quality Ip Holdings, Inc. Methods and compositions for increasing sex steroids and growth hormones
US9066953B2 (en) 2012-09-20 2015-06-30 Quality IP Holdings, LLC Methods for increasing endurance and fat metabolism in humans
US8715752B2 (en) 2012-09-20 2014-05-06 Quality Ip Holdings, Inc. Compositions for increasing human growth hormone levels
US10292957B2 (en) 2012-09-20 2019-05-21 Quality IP Holdings, LLC Compositions and methods for treating fibromyalgia
US8747923B2 (en) 2012-09-20 2014-06-10 Quality Ip Holdings, Inc. Methods for improving health in canines
CN110354265A (zh) 2012-10-24 2019-10-22 第一三共株式会社 用于肌萎缩性侧索硬化的治疗剂
CN105330720A (zh) * 2014-06-06 2016-02-17 深圳翰宇药业股份有限公司 一种制备马昔瑞林的方法
DK3939590T3 (da) 2015-09-21 2023-12-18 Lumos Pharma Inc Opdagelse og behandling af væksthormonmangel
US10894072B2 (en) 2017-02-13 2021-01-19 IP Quality Holdings, LLC Compositions and methods for treating fibromyalgia
US10288629B1 (en) 2017-12-19 2019-05-14 Aeterna Zentaris, Inc. Method of assessing growth hormone deficiency in humans by a macimorelin containing composition
WO2022017599A1 (en) 2020-07-22 2022-01-27 Aeterna Zentaris Gmbh A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof
JPH03502329A (ja) * 1988-01-28 1991-05-30 ポリゲン　ホールディング　コーポレイション 成長ホルモン放出活性を有するポリペプチド化合物類
US5536814A (en) * 1993-09-27 1996-07-16 La Jolla Cancer Research Foundation Integrin-binding peptides
AU684878B2 (en) * 1993-11-24 1998-01-08 Merck & Co., Inc. Compounds and the use thereof to promote the release of growth hormone(s)
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
US6025471A (en) * 1998-06-03 2000-02-15 Deghenghi; Romano Diazaspiro, azepino and azabicyclo therapeutic peptides
CA2407659C (en) * 2000-06-13 2010-11-09 Zentaris Ag Growth hormone secretagogues

Also Published As

Publication number Publication date
RU2270198C2 (ru) 2006-02-20
US6861409B2 (en) 2005-03-01
SK17562002A3 (sk) 2003-05-02
DE60130025D1 (de) 2007-09-27
CA2407659A1 (en) 2001-12-20
EP1289951B1 (en) 2005-08-17
BG110771A (bg) 2011-03-31
PT1344773E (pt) 2007-11-27
BRPI0111591B8 (pt) 2021-05-25
JP4932132B2 (ja) 2012-05-16
AU6606601A (en) 2001-12-24
FR19C1044I1 (pt) 2019-09-08
ATE362472T1 (de) 2007-06-15
DE60128494T2 (de) 2008-01-17
CZ20024095A3 (cs) 2003-05-14
TW200831076A (en) 2008-08-01
BG66130B1 (bg) 2011-06-30
SK287169B6 (sk) 2010-02-08
DK1289951T3 (da) 2005-12-19
CY1107710T1 (el) 2013-04-18
DE60130025T2 (de) 2008-05-15
US7297681B2 (en) 2007-11-20
IL153067A (en) 2010-05-31
JP2003335752A (ja) 2003-11-28
JP3522265B2 (ja) 2004-04-26
KR20030007889A (ko) 2003-01-23
NZ522280A (en) 2004-09-24
EP1289951A1 (en) 2003-03-12
DE60128494D1 (de) 2007-06-28
DE60112753D1 (de) 2005-09-22
PL363081A1 (en) 2004-11-15
DK1344773T3 (da) 2007-12-27
CN1431998A (zh) 2003-07-23
NL300999I2 (nl) 2019-08-28
WO2001096300A1 (en) 2001-12-20
NO323873B1 (no) 2007-07-16
BG110708A (en) 2010-12-30
CY1107793T1 (el) 2013-06-19
CN1232507C (zh) 2005-12-21
TWI305529B (en) 2009-01-21
ES2292900T3 (es) 2008-03-16
NL300999I1 (nl) 2019-07-17
HUP0302026A2 (hu) 2003-09-29
BG66216B1 (bg) 2012-05-31
BR0111591B1 (pt) 2014-02-04
ES2288724T3 (es) 2008-01-16
JP2004503536A (ja) 2004-02-05
ES2250416T3 (es) 2006-04-16
ATE302181T1 (de) 2005-09-15
US20020165343A1 (en) 2002-11-07
BR0111591A (pt) 2003-05-06
BG107379A (bg) 2003-09-30
HU229233B1 (en) 2013-09-30
MXPA02011899A (es) 2003-04-22
AU2001266066B2 (en) 2005-06-30
CA2407659C (en) 2010-11-09
PL216676B1 (pl) 2014-05-30
HUP0302026A3 (en) 2009-01-28
PT1524272E (pt) 2007-07-25
NO20025893D0 (no) 2002-12-09
IL153067A0 (en) 2003-06-24
KR100825109B1 (ko) 2008-04-25
HK1054224A1 (en) 2003-11-21
ATE370119T1 (de) 2007-09-15
AR029941A1 (es) 2003-07-23
CZ305279B6 (cs) 2015-07-15
CZ303173B6 (cs) 2012-05-16
BG66217B1 (bg) 2012-05-31
NO20025893L (no) 2003-02-10
US20040229823A1 (en) 2004-11-18
DE60112753T2 (de) 2006-06-29
FR19C1044I2 (fr) 2020-07-24

Similar Documents

Publication Publication Date Title
DK1524272T3 (da) Væksthormonsekretionsfremmere
NO20042182L (no) Kjemisk-modifiserte veksthormonkonjugater
ATE310728T1 (de) Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
DE60108654D1 (de) Mähdrescher
DE60118469D1 (de) Keramisches tragwerk
DE60128599D1 (de) Arbeitsgerät
DK1292733T3 (da) Kunstplæne
NO20024890D0 (no) Implantat
DK1333853T3 (da) Vækstfaktorkompleks
EE200200420A (et) Linesoliid - kristallivorm II
EE200300269A (et) Fibroblasti kasvufaktorid
DE60131102D1 (de) Monofilamentband
DE50109748D1 (de) Hydrolager
DE60030011D1 (de) Umpflanzungsmaschine
FR2806309B1 (fr) Implant
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
CU23064A3 (es) Conjunto implante dental-transportador
DE50104376D1 (de) Düngerstreuer
AT500246B8 (de) Chokerring
AT3550U3 (de) Futterautomat
FR2817889B1 (fr) Coffrage
ATA11602000A (de) Sonnenstandsnachführungssystem
SE9902459D0 (sv) Gallium
SE9900592D0 (sv) Gallium
DE60133669D1 (de) Insulinähnlichen wachstumsfaktors 1